US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Noninvasive cancer biomarkers are the alternatives for the invasive tissue biopsies used for the detection of tumor presence in various cancer types. These biomarkers are used for detecting the state of disease. There are various types of biomarkers available such as circulation tumor DNA, serum micro RNAs, DNA methylation based biomarker, and protein based biomarkers and others. Increased cancer occurrence rate and development in the diagnosis and treatment is creating the market for noninvasive cancer biomarkers. Moreover, increased funding by various government as well as non-government organization in the oncology segment also supports the overall market. Availability of large number of kits in the market and the marketing strategies used by various manufacturers is creating competitive environment for the noninvasive cancer biomarkers market. Continuous research in this field also deepens the molecular understanding of cancer which increases the availability of biomarkers in the market. With large number of research and diagnostic laboratories as well as healthcare facilities, North America holds the largest market for the usage of these noninvasive cancer biomarkers for disease diagnosis and prognosis. This is followed by Europe with increasing academic as well as bio-pharmaceutical research activities and the advancement in healthcare facilities. Asia-Pacific is expected to be the growing market for the noninvasive cancer biomarkers because of increasing prevalence of different types of cancers and along with this, government support in the availability of healthcare facilities also supports the growth over the region. The global Noninvasive Cancer Biomarkers market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Noninvasive Cancer Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Noninvasive Cancer Biomarkers market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Abbott Bio-Rad Merck Roche Sino Biological Thermo Fisher Scientific ... Segment by Regions North America Europe China Japan Segment by Type Protein Based Biomarkers DNA Based Biomarkers MRNA Based Biomarkers Micro RNA Based Biomarkers Segment by Application Hospitals Clinics Diagnostic Laboratories Academic and Research Institutes
Table of Contents Executive Summary 1 Noninvasive Cancer Biomarkers Market Overview 1.1 Product Overview and Scope of Noninvasive Cancer Biomarkers 1.2 Noninvasive Cancer Biomarkers Segment by Type 1.2.1 Global Noninvasive Cancer Biomarkers Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Protein Based Biomarkers 1.2.3 DNA Based Biomarkers 1.2.4 MRNA Based Biomarkers 1.2.5 Micro RNA Based Biomarkers 1.3 Noninvasive Cancer Biomarkers Segment by Application 1.3.1 Noninvasive Cancer Biomarkers Consumption Comparison by Application (2014-2025) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Diagnostic Laboratories 1.3.5 Academic and Research Institutes 1.4 Global Noninvasive Cancer Biomarkers Market by Region 1.4.1 Global Noninvasive Cancer Biomarkers Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Noninvasive Cancer Biomarkers Market Size 1.5.1 Global Noninvasive Cancer Biomarkers Revenue (2014-2025) 1.5.2 Global Noninvasive Cancer Biomarkers Production (2014-2025) 2 Global Noninvasive Cancer Biomarkers Market Competition by Manufacturers 2.1 Global Noninvasive Cancer Biomarkers Production Market Share by Manufacturers (2014-2019) 2.2 Global Noninvasive Cancer Biomarkers Revenue Share by Manufacturers (2014-2019) 2.3 Global Noninvasive Cancer Biomarkers Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Noninvasive Cancer Biomarkers Production Sites, Area Served, Product Types 2.5 Noninvasive Cancer Biomarkers Market Competitive Situation and Trends 2.5.1 Noninvasive Cancer Biomarkers Market Concentration Rate 2.5.2 Noninvasive Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Noninvasive Cancer Biomarkers Production Market Share by Regions 3.1 Global Noninvasive Cancer Biomarkers Production Market Share by Regions 3.2 Global Noninvasive Cancer Biomarkers Revenue Market Share by Regions (2014-2019) 3.3 Global Noninvasive Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019) ... | read more...